Change language dansk English suomi svenska

Generate Estimates Confirm Cancel Hide empty rows Show hidden rows DummyText

Scandinavian Medical Solutions A/S Estimate generation in progress, please wait... 0%

Quicksearch from your own companies XBRLDenmark Analyst: XBRLDenmark

Loading... Loading... Loading... Loading... Loading... Loading... Loading...

1.0 Bankruptcy Risk  2019 2019/9 2020 2020/9 2021 2021/9 2022 2022/9 2023 2023/9 2024 2024/9 2025e N/A 2026e N/A Bankruptcy risk for industry   1.1% 1.1% 1.1% 1.1% 1.1% 1.1% 1.1% 1.1%   Bankruptcy risk   7.7% 7.6% 7.0% 0.9% 0.6% 0.5% 7.0% 7.0%   Credit score (0-100)   33 32 33 89 96 99 34 34   Credit rating   BB BB BBB A AA AAA BBB BBB   Credit limit (mDKK)   0.0 0.0 0.0 6.1 8.9 9.9 0.0 0.0   How are these values calculated?   View the automatically generated explanation of bankruptcy risk 1.0 Income statement (mDKK)  2019 2019/9 2020 2020/9 2021 2021/9 2022 2022/9 2023 2023/9 2024 2024/9 2025e N/A 2026e N/A Net sales   31 42 72 111 191 226 226 226   Gross profit   31.2 41.9 71.6 22.7 34.7 37.5 0.0 0.0   EBITDA   31.2 41.9 71.6 15.4 21.1 20.3 0.0 0.0   EBIT   31.2 41.9 71.6 14.7 16.6 13.2 0.0 0.0   Pre-tax profit (PTP)   0.0 0.0 0.0 14.7 15.8 10.0 0.0 0.0   Net earnings   0.0 0.0 0.0 11.4 12.2 7.8 0.0 0.0   Pre-tax profit without non-rec. items   31.2 41.9 71.6 14.7 15.8 10.0 0.0 0.0     See the entire income statement 1.0 Balance sheet (mDKK)  2019 2019/9 2020 2020/9 2021 2021/9 2022 2022/9 2023 2023/9 2024 2024/9 2025e N/A 2026e N/A Tangible assets total   0.0 0.0 0.0 13.1 48.3 50.9 0.0 0.0   Shareholders equity total   3.1 4.9 24.1 62.2 74.5 82.5 81.2 81.2   Interest-bearing liabilities   0.0 0.0 0.0 0.1 7.5 21.9 0.0 0.0   Balance sheet total (assets)   9.4 17.1 44.6 106 164 174 81.2 81.2   Net Debt   0.0 0.0 0.0 -27.7 -0.5 13.5 -81.2 -81.2     See the entire balance sheet 1.0 Volume  2019 2019/9 2020 2020/9 2021 2021/9 2022 2022/9 2023 2023/9 2024 2024/9 2025e N/A 2026e N/A Net sales   31 42 72 111 191 226 226 226   Net sales growth   0.0% 34.5% 70.8% 54.3% 73.0% 18.3% 0.0% 0.0%   Gross profit   31.2 41.9 71.6 22.7 34.7 37.5 0.0 0.0   Gross profit growth   0.0% 34.5% 70.8% -68.3% 53.1% 8.1% -100.0% 0.0%   Employees   0 0 0 12 20 26 0 0   Employee growth %   0.0% 0.0% 0.0% 0.0% 66.7% 30.0% -100.0% 0.0%   Employee expenses   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Balance sheet total (assets)   9 17 45 106 164 174 81 81   Balance sheet change%   0.0% 82.1% 161.7% 137.7% 54.5% 6.1% -53.3% 0.0%   Added value   31.2 41.9 71.6 15.4 17.2 20.3 0.0 0.0   Added value %   100.0% 100.0% 100.0% 13.9% 9.0% 9.0% 0.0% 0.0%   Investments   0 0 0 13 31 -5 -51 0   Net sales trend   0.0 1.0 2.0 3.0 4.0 5.0 0.0 0.0   EBIT trend   1.0 2.0 3.0 4.0 5.0 5.0 0.0 0.0   1.0 Profitability  2019 2019/9 2020 2020/9 2021 2021/9 2022 2022/9 2023 2023/9 2024 2024/9 2025e N/A 2026e N/A EBITDA %   100.0% 100.0% 100.0% 13.9% 11.0% 9.0% 0.0% 0.0%   EBIT %   100.0% 100.0% 100.0% 13.3% 8.7% 5.8% 0.0% 0.0%   EBIT to gross profit (%)   100.0% 100.0% 100.0% 65.0% 47.9% 35.0% 0.0% 0.0%   Net Earnings %   0.0% 0.0% 0.0% 10.3% 6.4% 3.4% 0.0% 0.0%   Profit before depreciation and extraordinary items %   0.0% 0.0% 0.0% 10.8% 8.7% 6.6% 0.0% 0.0%   Pre tax profit less extraordinaries %   100.0% 100.0% 100.0% 13.3% 8.3% 4.4% 0.0% 0.0%   ROA %   332.9% 317.4% 232.2% 19.9% 12.4% 8.8% 0.0% 0.0%   ROI %   332.9% 317.4% 232.2% 27.9% 20.7% 13.6% 0.0% 0.0%   ROE %   0.0% 0.0% 0.0% 26.4% 17.9% 9.9% 0.0% 0.0%   1.0 Solidity  2019 2019/9 2020 2020/9 2021 2021/9 2022 2022/9 2023 2023/9 2024 2024/9 2025e N/A 2026e N/A Equity ratio %   100.0% 100.0% 100.0% 65.9% 50.5% 49.6% 100.0% 100.0%   Relative indebtedness %   0.0% 0.0% 0.0% 39.4% 46.8% 40.1% 0.0% 0.0%   Relative net indebtedness %   0.0% 0.0% 0.0% 14.3% 42.7% 36.4% -35.9% -35.9%   Net int. bear. debt to EBITDA, %   0.0% 0.0% 0.0% -180.2% -2.2% 66.7% 0.0% 0.0%   Gearing %   0.0% 0.0% 0.0% 0.2% 10.0% 26.5% 0.0% 0.0%   Net interest   0 0 0 0 0 0 0 0   Financing costs %   0.0% 0.0% 0.0% 481.0% 25.9% 33.3% 0.0% 0.0%   1.0 Liquidity  2019 2019/9 2020 2020/9 2021 2021/9 2022 2022/9 2023 2023/9 2024 2024/9 2025e N/A 2026e N/A Quick Ratio   0.0 0.0 0.0 1.3 0.5 0.5 0.0 0.0   Current Ratio   0.0 0.0 0.0 2.3 1.6 1.6 0.0 0.0   Cash and cash equivalent   0.0 0.0 0.0 27.8 7.9 8.3 0.0 0.0   1.0 Capital use efficiency  2019 2019/9 2020 2020/9 2021 2021/9 2022 2022/9 2023 2023/9 2024 2024/9 2025e N/A 2026e N/A Trade debtors turnover (days)   0.0 0.0 0.0 0.0 28.6 33.6 0.0 0.0   Trade creditors turnover (days)   0.0 0.0 0.0 1,239.7 838.7 767.8 0.0 0.0   Current assets / Net sales %   0.0% 0.0% 0.0% 83.8% 60.2% 54.0% 35.9% 35.9%   Net working capital   0.0 0.0 0.0 52.3 43.3 44.9 0.0 0.0   Net working capital %   0.0% 0.0% 0.0% 47.4% 22.6% 19.8% 0.0% 0.0%   1.0 Employee efficiency  2019 2019/9 2020 2020/9 2021 2021/9 2022 2022/9 2023 2023/9 2024 2024/9 2025e N/A 2026e N/A Net sales / employee   0 0 0 9 10 9 0 0   Added value / employee   0 0 0 1 1 1 0 0   Employee expenses / employee   0 0 0 0 0 0 0 0   EBITDA / employee   0 0 0 1 1 1 0 0   EBIT / employee   0 0 0 1 1 1 0 0   Net earnings / employee   0 0 0 1 1 0 0 0